A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Clinical trial NCT04051944 · COMPLETED
Trial details
- NCT number
- NCT04051944
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-21
- Primary completion
- 2021-11-10
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.